IND approval

Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, is spinning off its non-core units to focus on defense and aerospace b...

K Enter Holdings Inc., an umbrella entity of South Korea-based entertainment companies creating original entertainment content and managing related ...

South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

Japan has finally given the nod to the merger between South Korea’s No. 1 full-service carrier Korean Air Lines Co. and No. 2 Asiana Airlines ...

South Korea’s electrics components-to-energy conglomerate LS Group is set to start the securities business as it secured regulatory approval t...

The vast majority of creditors to Taeyoung Engineering & Construction Co. (Taeyoung E&C) have agreed to start debt restructuring for the tro...

South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...

South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...

South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...

BEIJING – CICC Capital, a unit of China International Capital Corp. (CICC), has entered the South Korean market with the launch of a private e...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...

South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...

SK Energy Co., a unit of South Korean oil refiner and battery maker SK Innovation Co., is spinning off its crude oil storage and shipment business t...

South Korean cosmetics giant Amorepacific Corp. said on Thursday its camellia-derived cosmetic ingredients got COSMetic Organic and natural Standard...

South Korea's Woori Bank plans to open two new branches in India in the first half of next year. The bank announced on Tuesday it has obtained ...

South Korea’s Hanwha Ocean Co. on Sunday announced its conclusion of a basic accord with the Houston-based American Bureau of Shipping (ABS) t...

HD Korea Shipbuilding & Offshore Engineering and HD Hyundai Heavy Industries Co. have secured Approval in Principle (AIP) from the UK's Lloyd's ...

Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...

South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...

South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...